Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

adjuvant therapy

  • You have access
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
    CHRISTIAN DOLL, CLAUDIUS STEFFEN, BENEDICTA BECK-BROICHSITTER, MAXIMILIAN RICHTER, KONRAD NEUMANN, ANNE POHRT, PHILIPP LOHNEIS, ANNIKA LEHMANN, MAX HEILAND, CARMEN STROMBERGER, ANNEKATRIN COORDES, KORINNA JOHRENS and JAN-DIRK RAGUSE
    Anticancer Research May 2022, 42 (5) 2405-2413; DOI: https://doi.org/10.21873/anticanres.15719
  • You have access
    Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study
    AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO and JUNJI FURUSE
    Anticancer Research February 2022, 42 (2) 893-902; DOI: https://doi.org/10.21873/anticanres.15547
  • You have access
    Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model
    NORIHIKO SUGISAWA, KAZUYUKI HAMADA, QINGHONG HAN, JUN YAMAMOTO, YU SUN, HIROTO NISHINO, KEI KAWAGUCHI, MICHAEL BOUVET, MICHIAKI UNNO and ROBERT M. HOFFMAN
    Anticancer Research September 2020, 40 (9) 4869-4874; DOI: https://doi.org/10.21873/anticanres.14489
  • You have access
    Is Perineural Invasion a Novel Prognostic Factor Useful to Tailor Adjuvant Treatment in Patients Treated With Primary Surgery for Cervical and Vulvar Carcinoma?
    ANGIOLO GADDUCCI, SABINA PISTOLESI, STEFANIA COSIO and ANTONIO GIUSEPPE NACCARATO
    Anticancer Research June 2020, 40 (6) 3031-3037; DOI: https://doi.org/10.21873/anticanres.14283
  • You have access
    Role of Adjuvant Chemotherapy in Pulmonary Carcinoids: An NCDB Analysis
    ROHIT GOSAIN, ADRIENNE GROMAN, SAI S. YENDAMURI, RENUKA IYER and SARBAJIT MUKHERJEE
    Anticancer Research December 2019, 39 (12) 6835-6842; DOI: https://doi.org/10.21873/anticanres.13900
  • You have access
    In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells
    YORIHISA MORO, YASUNAO KOGASHIWA, HIROYUKI SAKURAI, RYO TAKAHASHI, TORU KIMURA, MASATAKA HIRASAKI, YOSHIFUMI MATSUMOTO, MASASHI SUGASAWA and NAOYUKI KOHNO
    Anticancer Research November 2019, 39 (11) 6041-6047; DOI: https://doi.org/10.21873/anticanres.13810
  • You have access
    The Impact of EndoPredict Clinical Score on Chemotherapy Recommendations in Women with Invasive ER+/HER2− Breast Cancer Stratified as Having Moderate or Poor Prognosis by Nottingham Prognostic Index
    KINAN MOKBEL, UMAR WAZIR, ALI WAZIR, ABDUL KASEM and KEFAH MOKBEL
    Anticancer Research August 2018, 38 (8) 4747-4752; DOI: https://doi.org/10.21873/anticanres.12782
  • You have access
    A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer –ACTOR Study–
    MITSUKUNI SUENAGA, TAKASHI AKIYOSHI, EIJI SHINOZAKI, YOSHIYA FUJIMOTO, SATOSHI MATSUSAKA, TSUYOSHI KONISHI, SATOSHI NAGAYAMA, YOSUKE FUKUNAGA, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, TAKAHITO SUGISAKI, MASASHI UENO and TOSHIHARU YAMAGUCHI
    Anticancer Research March 2018, 38 (3) 1741-1747;
  • You have access
    A Comparison of the Performance of EndoPredict Clinical and NHS PREDICT in 120 Patients Treated for ER-positive Breast Cancer
    KINAN MOKBEL, UMAR WAZIR, HIBA EL HAGE CHEHADE, AISLING MANSON, CHRISTINA CHOY, VICTORIA MOYE and KEFAH MOKBEL
    Anticancer Research December 2017, 37 (12) 6863-6869;
  • You have access
    Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma
    ADAM ELZAGHEID, FATMA EMAETIG, WESAM ELSAGHAYER, FAIROUZ TORJMAN, MATTI LATTO, KARI SYRJÄNEN, YRJÖ COLLAN and SEPPO PYRHÖNEN
    Anticancer Research October 2016, 36 (10) 5301-5306;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire